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Introduction
Laparoscopic sleeve gastrectomy (LSG) and lap-
aroscopic Roux-en-Y gastric bypass (LRYGB) are as-
sociated with acceptable risk of postoperative mor-
bidity and mortality [1–7]. However, identification of 
high-risk patients plays an important role in every-
day work of the bariatric team [8, 9]. It may help in 
the process of selection of the most appropriate pro-
cedure for those patients, preoperative optimization 
of therapy for co-morbidity, and enhanced vigilance 
in the perioperative period [9–12].
DeMaria et al. introduced the Obesity Surgery 
Mortality Risk Score (OS-MRS) [13], which was val-
idated in a US multi-center study [14] and in a Ca-
nadian study [15]. The OS-MRS uses five clinical 
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A b s t r a c t
Introduction: Laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) are bar-
iatric procedures with acceptable risk of postoperative morbidities and mortalities, but identification of high-risk 
patients is an ongoing issue. DeMaria et al. introduced the Obesity Surgery Mortality Risk Score (OS-MRS), which 
was designed for mortality risk assessment but not perioperative morbidity risk.
Aim: To assess the possibility to use the OS-MRS to predict the risk of perioperative complications related to LSG 
and LRYGB.
Material and methods: Retrospective analysis of patients operated on for morbid obesity was performed. Patients 
were evaluated before and after surgery. We included 408 patients (233 LSG, 175 LRYGB). Perioperative compli-
cations were defined as adverse effects in the 30-day period. The Clavien-Dindo scale was used for description of 
complications. Patients were assigned to five grades and three classes according to the OS-MRS results, then risk of 
morbidity was analyzed.
Results: Complications were observed in 30 (7.35%) patients. Similar morbidity was related to both procedures 
(OR = 1.14, 95% CI: 0.53–2.44, p = 0.744). The reoperation and mortality rates were 1.23% and 0.49% respective-
ly. There were no significant differences in median OS-MRS value between the group without and the group with 
perioperative complications. There were no significant differences in OS-MRS between groups (p = 0.091). Obesity 
Surgery Mortality Risk Score was not related to Clavien-Dindo grades (p = 0.800).
Conclusions: It appears that OS-MRS is not useful in predicting risk of perioperative morbidity after bariatric proce-
dures.
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risk factors for assignment to one of three distinct 
classes. The OS-MRS has been applied previously for 
mortality risk assessment, but not risk of periopera-
tive morbidity.
Since mortality from laparoscopic bariatric sur-
gery is a  rare event, we tried to apply OS-MRS in 
assessment of perioperative bariatric procedures’ 
morbidity.
Aim
We aimed to assess the use of the OS-MRS to 
predict the risk of perioperative complications relat-
ed to LSG and LRYGB.
Material and methods
Material
From April 2009 to October 2015, 415 patients 
were operated on for morbid obesity in the 2nd De-
partment of General Surgery of Jagiellonian Uni-
versity Medical College. In the study we included 
408 patients (256 women, 152 men, 42.5 years old 
on average). In 233 patients LSG was performed 
(159 women, 74 men, mean age: 40.34 ±10.83) and 
in 175 LRYGB (97 women, 78 men, mean age 45.95 
±10.06) (Figure 1). Patients’ clinical characteristics, 
including surgical data, are presented in Table I. The 
association between OS-MRS class and incidence of 
the study endpoint in laparoscopic bariatric surgery 
is presented in Table II.
Methods
The study was based on retrospective analysis 
of prospectively collected data of patients operat-
ed on for morbid obesity. Inclusion criteria for bar-
iatric operations were Guidelines of the Metabolic 
and Bariatric Section of the Polish Surgical Society, 
i.e. body mass index (BMI) ≥ 35 kg/m2 with obesi-
ty comorbidities or BMI ≥ 40 kg/m2 with or with-
out comorbidities. Patients were evaluated prior to 
surgery and afterwards underwent LSG or LRYGB. 
Patients’ demographic and clinical data, including 
a detailed description of the intraoperative adverse 
effects and perioperative complications, were ob-
tained. Perioperative complications were defined as 
adverse effects which occurred in the 30 days after 
the procedure. The Clavien-Dindo scale was used for 
description of complications [16].
The risk of postoperative complications was as-
sessed using the OS-MRS scale. One point was as-
signed to each of 5 preoperative variables including 
BMI ≥ 50 kg/m2, male gender, arterial hypertension, 
known risk factors for pulmonary embolism, e.g. 
previous thromboembolism, preoperative vena cava 
filter, hypoventilation, pulmonary hypertension and 
age ≥ 45 years. Patients were divided into five cat-
egories according to the OS-MRS results. The class 
of the risk assigned to each patient was dependent 
on the total points obtained. A score of zero or one 
point = class A; two or three points = class B; and 
four or five points = class C. 
Enrollment Assessed for eligibility (n = 415)
Admitted for laparoscopic surgery (n = 408)
Excluded (n = 7):
• Revision surgery (n = 5)
• Different procedure (n = 2)
Allocated to LSG (n = 233)
• Received allocated intervention (n = 233)
Allocated to LRYGB (n = 175)
• Received allocated intervention (n = 175)
Allocation
Perioperative complications (n = 18)
Non-complicated patients (n = 215)
Perioperative complications (n = 12)
Non-complicated patients (n = 163)
Follow-up
Figure 1. Study flow chart
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Ethics
All procedures performed in studies involving 
human participants were in accordance with the 
ethical standards of the institutional and national 
research committee and with the 1964 Declaration 
of Helsinki and its later amendments or comparable 
ethical standards. The study was approved by the 
Bioethics Committee of the Jagiellonian University.
Statistical analysis
To assess the significance of the observed in-
tergroup differences of frequencies of qualitative 
data, the χ2 test with and without Yates’ correction 
and Fisher’s exact test were used. The quantitative 
data were processed with Student’s t-test or the 
Mann-Whitney test for non-parametric variables. 
Univariate logistic regression analyses were con-
ducted for OR with 95% CI calculations. Statistical 
significance was observed with p-value under 0.05. 
Statistica 10.0 PL software was used for the con-
ducted analysis.
Results
Complications were observed in 30 (7.35%) pa-
tients. Similar morbidity was related to both proce-
dures (LRYGB vs. LSG; OR = 1.14, 95% CI: 0.53–2.44, 
p = 0.744). The most common complication was rhab-
domyolysis, observed in 9 patients (2.2% of total). 
The 30-day reoperation rate and mortality rate were 
1.23% and 0.49% respectively. Causes of death were 
pulmonary embolism and rhabdomyolysis in the first 
(OS-MRS class C), and operation site’s strangulated 
hernia with peritonitis and jejunojejunal anastomo-
Table I. Patients’ characteristics
Parameter LSG LRYGB P-value
Factors dependent on patient:
Number of patients, n (%) 233 (57.11) 175 (42.89) –
Females, n (%) 159 (38.97) 97 (23.77) 0.008
Males, n (%) 74 (18.14) 78 (19.12)  
Age, mean ± SD [years] 40.34 ±10.83 45.95 ±10.06 0.302
Maximal preoperative weight, median (IQR) [kg] 132 (120; 147) 141 (126; 160) < 0.001
Maximal preoperative BMI, median (IQR) [kg/m2] 45.91 (42.48; 50.19) 48.83 (44.08; 54.08) < 0.001
Weight on day of surgery, median (IQR) [kg] 130 (117; 143) 135 (120; 155) 0.004
BMI on day of operation, median (IQR) [kg/m2] 44.82 (41.33; 48.55) 46.76 (41.87; 52.63) 0.002
Preoperative weight loss, median (IQR) [kg]  2 (0; 6) 4 (0; 9) 0.002
Factors dependent on procedure:
Operative time, median (IQR) [min] 110 (85; 140) 140 (100; 180) < 0.001
Additional procedure during procedure, n (%) 3 (1.29) 4 (2.29) 0.702
Intraoperative adverse effects, n (%) 4 (1.72) 10 (5.71) 0.055
Operated on by experienced operator, n (%) 28 (12.02) 104 (59.43) < 0.001
Operated on by operator on bariatric learning curve, n (%) 205 (87.98) 71 (40.57)
Table II. Association between OS-MRS class and incidence of the study endpoint in laparoscopic bariatric 
surgery (total N = 408)
OS-MRS class OS-MRS Gradea Number of patients, n (%) Endpointb, n (% of patients)
A 0–1 199 (48.77) 20 (4.9)
B 2–3 115 (28.19) 4 (0.98)
C 4–5 94 (23.04) 6 (1.47)
aNumber of risk factors: age ≥ 45 years, male gender, BMI ≥ 50 kg/m2, hypertension (or treatment for hypertension) and high-risk status for thromboembolism. 
bEnd point: perioperative morbidity, including mortality, defined as laparoscopic bariatric surgery adverse effects diagnosed in the 30-day perioperative period.
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sis leak in the second patient (OS-MRS class B). Both 
patients were submitted to LRYGB (Table III).
The OS-MRS yields quantitative, but it could be 
converted to qualitative categories. The Mann-Whit-
ney test revealed no statistically significant differ-
ence between the median OS-MRS value of 3 (2-3) 
of the group without perioperative complications 
and the median OS-MRS value of 3 (1-3) calculated 
for the group with perioperative complications. 
The study revealed no statistically significant 
difference in OS-MRS class between the group with 
complications and the group without complications 
(p = 0.091). We did not observe a  significant dif-
ference between groups A  and B in OS-MRS class 
(p = 0.059), or between A and C (p = 0.513) or B and C 
(p = 0.303) or A and B + C (p = 0.095) (Table IV).
We did not observe any statistically significant 
difference in OS-MRS between different Clavien-Din-
do grades (p = 0.8). There was no significant relation 
between frequency of A or B + C OB-MRS class cate-
gories and Clavien-Dindo class I–II or III–V categories 
(p = 0.648) (Table V).
Finally, we used univariate logistic regression to 
assess the influence of increasing OS-MRS class or 
grade on the odds ratio of morbidity. The odds ra-
tio of perioperative complications did not increase 
Table III. Perioperative (≤ 30 days) complications according to Clavien-Dindo scale
C-D Grade Complications N (%) LSG LRYGB
5 Pulmonary embolism and rhabdomyolysis 
(patient death)
1 (0.25) 0 1 (0.57%)
Peritonitis, strangulated operation site hernia, 
jejunojejunal anastomosis leak (relaparotomy, 
patient death)
1 (0.25) 0 1 (0.57%)
4b Cardiorespiratory failure (ICU stay) 2 (0.49) 1 (0.43%) 1 (0.57%)
4a Pneumonia, ARDS (ICU stay) 1 (0.25) 0 1 (0.57%)
3b Gastrointestinal leakage 6 (1.53) 5 (2.15%) 1 (0.57%)
Bleeding from suture line
(relaparoscopy)
2 (0.49) 1 (0.43%) 1 (0.57%)
Petersen’s space hernia
(relaparoscopy)
1 (0.25) 0 1 (0.57%)
2 Pneumonia 1 (0.25) 0 1 (0.57%)
Fever of unknown origin 1 (0.25) 0 1 (0.57%)
1 Delayed gastric emptying* 5 (1.23) 4 (1.72%) 1 (0.57%)
Dehydration* 1 (0.25) 1 (0.43%) 0
Prolonged drainage 1 (0.25) 1 (0.43%) 0
Rhabdomyolysis 8 (1.96) 6 (2.58%) 2 (1.14%)
Total 30 (7.35) 18 (7.73%) 12 (6.86%)
*1 patient was diagnosed with both complications.
Table IV. Pearson’s χ2 test of intergroup differences in OS-MRS frequencies
OS-MRS class Group with 
complications
Group without 
complications
P-value
A vs. B B vs. C A vs. C A vs. B + C
A 4 (13.33%) 111 (29.37%) 0.059 0.303 0.513 0.095
B 20 (66.67%) 179 (47.35%)
C 6 (20.00%) 88 (23.28%)
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Table V. OS-MRS classes categorized according to Clavien-Dindo grades
OS-MRS class Clavien-Dindo grade P-value
I II III IV V
A n (% of total) 2 (6.67) 0 (0.00) 1 (3.33) 1 (3.33) 0 (0.00) 0.800
B n (% of total) 9 (30.00) 1 (3.33) 7 (23.33) 2 (6.67) 1 (3.33)
C n (% of total) 3 (10.00) 1 (3.33) 1 (3.33) 0 (0.00) 1 (3.33)
significantly with either OS-MRS grade (OR = 1.24, 
95% CI: 0.94–1.63, p = 0.133) or with OS-MRS class 
(OR = 0.78, 95% CI: 0.46–1.32, p = 0.352).
Regarding mortality, OS-MRS did not predict an 
increase in the odds ratio of patients’ death (OS-
MRS grade: OR = 1.95, 95% CI: 0.58–6.60, p = 0.281; 
OS-MRS class: OR = 0.31, 95% CI: 0.03–3.12, p = 
0.316).
Discussion
One of the first attempts to create a simple tool 
for preoperative assessment of a morbidly obese pa-
tient’s mortality risk was the OS-MRS, proposed in 
2007 by DeMaria et al. [13], which was validated by 
the author [14] and in other studies [15, 17]. Sarela 
et al. tried to use it for prediction of perioperative 
morbidity [18]. Orłowski et al. reported that the 
OS-MRS can be a useful clinical tool in the decision 
about an optimal bariatric procedure, depending on 
the risk of postoperative complications [19]. Other 
scoring systems were developed by Flum et al. based 
on analyzing the results of the Longitudinal Assess-
ment of Bariatric Surgery (LABS) [20], or metabolic 
acuity score by Blackstone et al. [21] or scales of Gup-
ta et al. and Turner et al. derived from the National 
Surgical Quality Improvement Program (NSQIP) da-
tabase of the American College of Surgeons [22, 23].
The simplicity of the OS-MRS scale encourages 
its use in common surgical practice, while using five 
clinical variables to estimate patients’ postoperative 
risk preoperatively. A limitation is that this scale was 
developed for the analysis of mortality after LRYGB, 
although it was tested in predicting morbidity [18].
In this study we found limited value of OS-MRS 
for estimating the perioperative morbidity risk of 
morbidly obese patients submitted to laparoscopic 
bariatric procedures, including laparoscopic sleeve 
gastrectomy and laparoscopic Roux-en-Y gastric by-
pass. In our study there were no significant differ-
ences in OS-MRS grade between groups with and 
without perioperative complications. The OS-MRS 
classes did not significantly differ between groups. 
Only a  few studies have evaluated use of the 
OS-MRS in predicting postoperative morbidity risk. 
Sarela et al. demonstrated that the OS-MRS is in-
dependently predictive of the risk of postoperative 
adverse events after gastric band, Roux-en-Y gastric 
bypass, sleeve gastrectomy, or biliopancreatic diver-
sion [18]. An increase in OS-MRS class resulted in an 
increase of postoperative adverse effects by 300%. 
Similar results were recently presented in an analysis 
performed by Lorente et al. [24]. They demonstrated 
a significant association between the OS-MRS scale 
and morbidity increasing from 7.3% in group A  to 
50% in group C. Our group included a similar number 
of patients, but univariate logistic regression did not 
demonstrate an influence of OS-MRS class or grade 
on increase in morbidity or mortality. 
The use of the OS-MRS in prediction of mortali-
ty was recently confirmed in a systematic review by 
Thomas et al. [17]. Likew in our study, patients who 
died in the perioperative period were in higher OS-
MRS classes. Despite encouraging advantages, the 
OS-MRS failed to identify patients at higher postop-
erative morbidity risk and should be used according 
to its primary purpose.
Conclusions
The OS-MRS is not a useful tool in predicting risk 
of perioperative morbidity after bariatric procedures.
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